EDTUTC-4 New YorkLog in Sign up

IMMX
Immix Biopharma, Inc. Common Stock
stockNASDAQ

Market OpenOct 5, 2026 2:38:53 PM EDT

10.15USD+4.907%(+0.47)1,015,213

10.14Bid10.19Ask0.05Spread

Pre-marketOct 5, 2026 9:29:30 AM EDT

9.57USD-1.136%(-0.11)

IMMX News

Day breaks

08:45 AM EDTImmix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference ·

GlobeNewswire Inc.

05:20 PM EDTImmix Biopharma closes $117.1m stock offering ·

Investing.com

05:15 PM EDTImmix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock ·

GlobeNewswire Inc.

05:08 AM EDTCitizens reiterates Immix Biopharma stock rating on trial data ·

Investing.com

03:42 PM EDTImmix Biopharma, Inc. (IMMX) Shareholder/Analyst Call Transcript ·

Seeking Alpha

09:40 AM EDTImmix Biopharma's NXC-201 Shows 89% Complete Response Rate In AL Amyloidosis ·

RTTNews

09:13 AM EDTImmix rises after new mid-stage trial data for AL amyloidosis therapy ·

Seeking Alpha

07:33 AM EDTImmix Biopharma prices $125M stock offering ·

Seeking Alpha

07:05 AM EDTImmix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock ·

GlobeNewswire Inc.

07:00 AM EDTImmix Biopharma Announces 89% Complete Response Rate at Interim Update Across All NEXICART-2 Patients, with MRD-Negativity Indicating Potential to Reach up to 98% Complete Response Rate, Supporting Potential Best-in-Class Therapy for Relapsed/Refractory AL Amyloidosis ·

GlobeNewswire Inc.

12:23 PM EDTTop BioTech SMidcap Stock: Mizuho Analyst Highlights IMMX ·

Investing.com

08:44 AM EDTMizuho raises Immix Biopharma stock price target to $26 on expansion ·

Investing.com